SOFIA (Bulgaria), December 22 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Tuesday that its CEO Ognyan Donev acquired 2,000 shares in the company at a price of 3.12 levs ($1.95/1.59 euro) per share.